Literature DB >> 6257396

Characterization of protein kinase activity associated with the transforming gene product of Fujinami sarcoma virus.

R A Feldman, T Hanafusa, H Hanafusa.   

Abstract

Fujinami sarcoma virus (FSV), a newly characterized avian sarcoma virus, produces a protein of 140,000 daltons (p140) in infected cells. p140 is the product of a fused gene consisting of a part of the gag gene of avian retrovirus and FSV-unique sequences which are not related to the src sequences of Rous sarcoma virus. In vivo, p140 was found to be phosphorylated at both serine and tyrosine residues. Immunoprecipitates of p140 with antiserum against gag gene-coded proteins had a cyclic nucleotide-independent protein kinase activity which phosphorylated p140 itself, rabbit IgG of the immune complex and alpha-casein, an externally added soluble protein substrate. The phosphorylation was specific to tyrosine of the substrate proteins. p140 was phosphorylated in vitro at the same two tyrosine residues that were phosphorylated in vivo. The phosphate transferred to tyrosine residues of p140 forms a stable bond: it does not turn over during the kinase reaction, and the 32P-phosphate of p140 labeled in vitro or in vivo is not transferred to alpha-casein. FSV-p140 differs from p60src, the transforming protein of Rous sarcoma virus, in its marked preference of Mn2+ to Mg2+ ions, and in its inability to use GTP instead of ATP as the donor of gamma-phosphate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257396     DOI: 10.1016/0092-8674(80)90552-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  86 in total

1.  Transcription of a quail gene expressed in embryonic retinal cells is shut off sharply at hatching.

Authors:  M Guermah; P Crisanti; D Laugier; P Dezelee; L Bidou; B Pessac; G Calothy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Phosphatidylinositol kinase activity in virus-transformed and nontransformed cells.

Authors:  S Sugano; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements.

Authors:  K Alexandropoulos; S A Qureshi; M Rim; V P Sukhatme; D A Foster
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

4.  Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus.

Authors:  B Mathey-Prevot; M Shibuya; J Samarut; H Hanafusa
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Phosphorylation of the ribosomal protein S6 is elevated in cells transformed by a variety of tumor viruses.

Authors:  J Blenis; R L Erikson
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis.

Authors:  I G Macara; G V Marinetti; P C Balduzzi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses.

Authors:  W S Neckameyer; L H Wang
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

8.  Monoclonal antibodies to the transforming protein of Fujinami avian sarcoma virus discriminate between different fps-encoded proteins.

Authors:  J Ingman-Baker; E Hinze; J G Levy; T Pawson
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  A novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences.

Authors:  R Jia; B J Mayer; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Four different classes of retroviruses induce phosphorylation of tyrosines present in similar cellular proteins.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.